Motherisk Rounds. The Safety of Methimazole and Propylthiouracil in Pregnancy: A Systematic Review.

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 11, 2012, Pages 1077-1086

  Hackmon, Rinat ^a,b   Blichowski, Monica ^a,b   Koren, Gideon ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Birth defects; Hyperthyroidism; Methimazole; Pregnancy; Propylthiouracil

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE; ANTITHYROID AGENT;

ARTICLE; CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EXPOSURE; DRUG SAFETY; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTHYROIDISM; LIVER FAILURE; LIVER TOXICITY; PREGNANCY; RISK ASSESSMENT; SKIN APLASIA; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CASE CONTROL STUDY; CONGENITAL MALFORMATION; FEMALE; GESTATIONAL AGE; PREGNANCY COMPLICATION; REVIEW; TOXIC HEPATITIS;

ABNORMALITIES, DRUG-INDUCED; ANTITHYROID AGENTS; CASE-CONTROL STUDIES; DRUG-INDUCED LIVER INJURY; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTHYROIDISM; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PROPYLTHIOURACIL;

EID: 84876236129     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35438-X     Document Type: Article

References (54)

1. Earl R., Crowther C.A., Middleton P. Interventions for preventing and treating hyperthyroidism in pregnancy. Cochrane Database Syst Rev 2010, 9. CD008633.
2. Rivkees S.A. 63 years and 715 days to the "boxed warning": unmasking of the propylthiouracil problem. Int J Pediatr Endocrinol 2010 2010, pii: 658267. Epub 2010 Jul 12.
3. Rashid M., Rashid M.H. Obstetric management of thyroid disease. Obstet Gynecol Surv 2007, 680-688.
4. Mestman J.H., Goodwin T.M., Montoro M.M. Thyroid disorders of pregnancy. Endocrinol Metab Clin North Am 1995, 24:41-71.
5. Rosenfeld H., Ornoy A., Shechtman S., Diav-Citrin O. Pregnancy outcome, thyroid dysfunction and fetal goiter after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol 2009, 68:609-617.
6. Barbero P., Ricagni C., Mercado G., Bronberg R., Torrado M. Choanal atresia associated with prenatal methimazole exposure: three new patients. Am J Med Genet A 2004, 129:83-86.
7. Barbero P., Valdez R., Rodriguez H., Tiscornia C., Mansilla E., Allons A., et al. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-controlled study. Am J Med Genet 2008, 146:2390-2395.
8. Valdez R.M., Barbero P.M., Liascovich R.C., De Rosa L.F., Aguirre M.A., Alba L.G. Methimazole embryopathy: a contribution to defining the phenotype. Reprod Toxicol 2007, 23:253-255.
9. Okosieme O.E., Marx H., Lazarus JH. Medical management of thyroid dysfunction in pregnancy and the postpartum. Expert Opin Pharmacother 2008, 13:2281-2293.
10. Chattaway J.M., Klesper T.B. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy. Ann Pharmacother 2007, 41:1018-1022.
11. Lazarus J. Thyroid function in pregnancy. Br Med Bull 2011, 97:137-148.
12. American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists.Number 37, August 2002. (Replaces practice bulletin no. 32, November2001). Thyroid disease in pregnancy. Obstet Gynecol 2002, 100:387-396.
13. Mortimer R.H., Cannell G.R., Addison R.S., Johnson L.P., Roberts M.S., Bernus I. Methimazole and propylthioracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997, 82:3099-3102.
14. Mandel S.J., Cooper D.S. The use of antithyroid drugs m pregnancy and lactation. J Clin Endocrinol Metab 2001, 86:2354-2359.
15. Rivkees S. Pediatric Graves' disease: controversies in management. Horm Res Paediatr 2010, 74:305-311.
16. Harris J., Robert E., Kallen B. Epidemiology of choanal atresia with special reference to the CHARGE association. Pediatrics 1997, 99:363-367.
17. Clementi M., Di Gianantonio E., Pelo E., Mammi I., Basile R.T., Tenconi R. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999, 83:43-46.
18. Chan G.W., Mandel SJ. Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab 2007, 3:470-477.
19. Momotani N., Ito K., Hamada N., Ban Y., Nishikawa Y., Mimura T. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol(Oxf) 1984, 695-700.
20. Wing D.A., Millar L.K., Koonings P.P., Montoro M.N., Mestman J.H. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 1993, 170:90-95.
21. Kim H.J., Kim B.H., Han Y.S., Yang I., Kim K.J., Dong S.H., et al. The incidence and clinical characteristics of symptomatic propylthiouracil- induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. Am J Gastroenterol 2001, 96:165-169.
22. Gianantonio E., Schaefer C., Di Mastroiacovo P.P., Cournot M.P., Benedicenti F., Reuvers M., et al. Adverse effects of prenatal methimazole exposure. Teratology 2001, 64:262-266.
23. Mujtaba Q., Burrow G.N. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol 1975, 46:282-286.
24. Eisenstein Z., Weiss M., Katz Y., Bank H. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 1992, 151:558-559.
25. Van Dijke C.P., Heydendael R.J., De Kleine M.J. Methimazole, carbimazole and congenital skin defects. Ann Intern Med 1987, 106:60-61.
26. Ferraris S., Valenzise M., Lerone M., Divizia M.T., Rosaia L., Blaid D., et al. Malformations following methimazole exposure in utero: an open issue. Birth Defects Res A Clin Mol Teratol 2003, 67:989-992.
27. Johnsson E., Larsson G., Ljunggren M. Severe malformations in infant born to hyperthyroid woman on Methimazole. Lancet 1997, 350:1520.
28. Gripp K.W., Kuryan R., Schnur R.E., Kothawala M., Davey L.R., Antunes M.J., et al. Grade 1 microtia, wide anterior fontanel and novel type tracheo¬esophageal fistula in methimazole embryopathy. Am J Med Genet A 2011, 155:526-533.
29. Greenberg F. Coanal atresia and athelia: methimazole teratogenicity or a new syndrome. Am J Med Genet 1987, 28:931-934.
30. del Cacho M.J., Frias M.L. Choanal atresia following methimazole exposure postconceptional. J Perinat Med 2001, 29(1):323. Suppl.
31. Milham S., Ellege W. Maternal methimazole and congenital defects in children. Teratology 1995, 5:125.
32. Iwayama H., Hosono H., Yamamoto H., Oshiro M., Ueda N. Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero. Birth Defects Res A Clin Mol Teratol 2007, 79:680-684.
33. Osorio M., Wohllk N., Pineda G. Treatment of hyperthyroidism during pregnancy: experience with 19 cases [article in Spanish]. Rev Med Chil 1993, 21:660-665.
34. Morris C.V., Goldstein R.M., Cofer J.B., Solomon H., Klintmalm GB. An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy. Clin Transpl 1989, 311.
35. Bahn R.S., Burch H.S., Cooper D.S., Garber J.R., Greenlee C.M., Klein I.L., et al. The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 2009, 19:673-674.
36. Morris C.V., Goldstein R.M., Cofer J.B., Solomon H., Klintmalm G.B. An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy. Clin Transpl 1989, 311.
37. Parker W. Propylthiouracil-induced hepatotoxicity. Clin Pharm 1982, 1:474-478.
38. Hayashida C.Y., Duatre A.J., Sato A.E., Yamashiro-Kanashiro E.H. Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil. J Endocrinol Invest 1990, 13:937-941.
39. Hare J.W., Kitzmiller J.L. Diabetes and Graves disease complicating pregnancy. Obstet Gynecol 1978, 51:655-658.
40. Devi L., Tandon R., Kumari I., Huria A., Goel P. Thyrotoxicosis in pregnancy complicated by propylthiouracil-induced hepatitis. Thyroid Science 2010, 5(2):1-3.
41. Diav-Citrin O., Omoy A. Teratogen update: antithyroid drugs- methimazole, carbimazole and propylthiouracil. Teratology 2002, 65:38-44.
42. M.Rosove Agranulocytosis and antithyroid drugs. West J Med 1977, 126:339-343.
43. Tajiri J., Noguchi S. Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?. Thyroid 2005, 15:292-297.
44. Azizi F., Amouzegar A. Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol 2011, 164:871-876.
45. Momotani N., Noh J.Y., Ishikawa N., Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 1997, 82:3633-3636.
46. Karg E., Bereg E., Gaspar L., Katona M., Turi S. Aplasia cutis congenita after methimazole exposure in utero. Pediatr Dermatol 2004, 21:491-494.
47. Nakamura S., Nishikawa T., Isaji M., Ishimori M., Shimizu N., Iwamura M., et al. Aplasia cutis congenita and skull defects after exposure to methimazole in utero. Intern Med 2005, 44:1202-1203.
48. Valdez R.M., Barbero P.M., Liascovich R.C., De Rosa L.F., Aguirre M.A., Alba LG. Methimazole embryopathy: a contribution to defining the phenotype. Reprod Toxicol 2007, 23:253-255.
49. Ozgen H.M., Reuvers-Lodewijks W.E., Hennekam RC. Possible teratogenic effects of thiamazole [article in Dutch]. Ned Tijdschr Geneeskd 2006, 150:101-104.
50. B.Hall Methimazole as a teratogenic etiology of choanal atresia/multiple congenital anomaly syndrome. Am J Hum Genet 1997, 61(4):100.
51. Vogt T., Stolz W., Landthaler M. Aplasia cutis congenita after exposure to methimazole: a causal relationship?. Br J Dermatol 1995, 133:994-996.
52. Farine D., Maidman J., Rubin S., Chao S. Elevated alpha-fetoprotein in pregnancy complicated by aplasia cutis after exposure to methimazole. Obstet Gynecol 1988, 996-997.
53. Ono K., Kikuchi A., Takikawa K.M., Hiroma T., Yoshizawa K., Sunagawa S., et al. Hernia of the umbilical cord and associated ileal prolapse through a patent omphalomesenteric duct: prenatal ultrasound and MRI findings. Fetal Diagn Ther 2009, 25:72-75.
54. Lollgen R.M., Calza A.M., Schwitzgebel V.M., Pfister RE. Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero. J Pediatr Endocrinol Metab 2011, 24(3,4):215-218.